Xu Y, Lu P, Gao M, Wang R, Li Y, Guo R
World J Clin Oncol. 2024; 15(3):419-433.
PMID: 38576593
PMC: 10989267.
DOI: 10.5306/wjco.v15.i3.419.
Yang T, Feng J, Yao R, Feng Q, Shen J
Insights Imaging. 2024; 15(1):69.
PMID: 38472447
PMC: 10933237.
DOI: 10.1186/s13244-024-01637-4.
Okazumi S, Ohira G, Hayano K, Aoyagi T, Imanishi S, Matsubara H
J Clin Med. 2024; 13(2).
PMID: 38276137
PMC: 10816440.
DOI: 10.3390/jcm13020632.
Cheng X, Zhang Y, Zhu M, Sun R, Liu L, Li X
BMC Med Imaging. 2023; 23(1):145.
PMID: 37779188
PMC: 10544369.
DOI: 10.1186/s12880-023-01089-0.
Zhou Y, Song L, Xia J, Liu H, Xing J, Gao J
Front Oncol. 2023; 13:1225180.
PMID: 37664013
PMC: 10473874.
DOI: 10.3389/fonc.2023.1225180.
Combination of clinical, radiomic, and "delta" radiomic features in survival prediction of metastatic gastroesophageal adenocarcinoma.
Krishna S, Sertic A, Liu Z, Liu Z, Darling G, Yeung J
Front Oncol. 2023; 13:892393.
PMID: 37645426
PMC: 10461093.
DOI: 10.3389/fonc.2023.892393.
A radiomics nomogram based on contrast-enhanced CT for preoperative prediction of Lymphovascular invasion in esophageal squamous cell carcinoma.
Wang Y, Bai G, Huang W, Zhang H, Chen W
Front Oncol. 2023; 13:1208756.
PMID: 37465108
PMC: 10351375.
DOI: 10.3389/fonc.2023.1208756.
Computed tomography-based radiomic analysis for predicting pathological response and prognosis after neoadjuvant chemotherapy in patients with locally advanced esophageal cancer.
Oda S, Kuno H, Hiyama T, Sakashita S, Sasaki T, Kobayashi T
Abdom Radiol (NY). 2023; 48(8):2503-2513.
PMID: 37171586
DOI: 10.1007/s00261-023-03938-6.
Predicting the efficacy of radiotherapy for esophageal squamous cell carcinoma based on enhanced computed tomography radiomics and combined models.
Liu J, Yang X, Mao X, Wang T, Zheng X, Feng G
Front Oncol. 2023; 13:1089365.
PMID: 37007134
PMC: 10061127.
DOI: 10.3389/fonc.2023.1089365.
Research Progress on the Predicting Factors and Coping Strategies for Postoperative Recurrence of Esophageal Cancer.
Zhang Y, Zhang Y, Peng L, Zhang L
Cells. 2023; 12(1).
PMID: 36611908
PMC: 9818463.
DOI: 10.3390/cells12010114.
Prediction of distant metastasis in esophageal cancer using a radiomics-clinical model.
Zhu C, Mu F, Wang S, Qiu Q, Wang S, Wang L
Eur J Med Res. 2022; 27(1):272.
PMID: 36463269
PMC: 9719117.
DOI: 10.1186/s40001-022-00877-8.
Change in Density Not Size of Esophageal Adenocarcinoma During Neoadjuvant Chemotherapy Is Associated with Improved Survival Outcomes.
Tankel J, Soderstrom H, Reizine E, Artho G, Calderone A, Mueller C
J Gastrointest Surg. 2022; 26(12):2417-2425.
PMID: 36214951
DOI: 10.1007/s11605-022-05422-w.
Computed tomography-based radiomic analysis for prediction of treatment response to salvage chemoradiotherapy for locoregional lymph node recurrence after curative esophagectomy.
Gu L, Liu Y, Guo X, Tian Y, Ye H, Zhou S
J Appl Clin Med Phys. 2021; 22(11):71-79.
PMID: 34614265
PMC: 8598151.
DOI: 10.1002/acm2.13434.
Radiomics in the Setting of Neoadjuvant Radiotherapy: A New Approach for Tailored Treatment.
Nardone V, Boldrini L, Grassi R, Franceschini D, Morelli I, Becherini C
Cancers (Basel). 2021; 13(14).
PMID: 34298803
PMC: 8303203.
DOI: 10.3390/cancers13143590.
Contrast-Enhanced CT-Based Radiomics Analysis in Predicting Lymphovascular Invasion in Esophageal Squamous Cell Carcinoma.
Li Y, Yu M, Wang G, Yang L, Ma C, Wang M
Front Oncol. 2021; 11:644165.
PMID: 34055613
PMC: 8162215.
DOI: 10.3389/fonc.2021.644165.
Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy.
Tang S, Ou J, Liu J, Wu Y, Wu C, Chen T
Cancer Imaging. 2021; 21(1):38.
PMID: 34039403
PMC: 8157695.
DOI: 10.1186/s40644-021-00407-5.
CT Texture Analysis for Preoperative Identification of Lymphoma from Other Types of Primary Small Bowel Malignancies.
Liu S, Zhang C, Liu R, Li S, Xu F, Liu X
Biomed Res Int. 2021; 2021:5519144.
PMID: 33884262
PMC: 8041543.
DOI: 10.1155/2021/5519144.
Review of Value of CT Texture Analysis and Machine Learning in Differentiating Fat-Poor Renal Angiomyolipoma from Renal Cell Carcinoma.
Zhang Y, Li X, Lv Y, Gu X
Tomography. 2020; 6(4):325-332.
PMID: 33364422
PMC: 7744193.
DOI: 10.18383/j.tom.2020.00039.
Advanced analytics and artificial intelligence in gastrointestinal cancer: a systematic review of radiomics predicting response to treatment.
Wesdorp N, Hellingman T, Jansma E, van Waesberghe J, Boellaard R, Punt C
Eur J Nucl Med Mol Imaging. 2020; 48(6):1785-1794.
PMID: 33326049
PMC: 8113210.
DOI: 10.1007/s00259-020-05142-w.
Pretreatment CT-Based Radiomics Signature as a Potential Imaging Biomarker for Predicting the Expression of PD-L1 and CD8+TILs in ESCC.
Wen Q, Yang Z, Zhu J, Qiu Q, Dai H, Feng A
Onco Targets Ther. 2020; 13:12003-12013.
PMID: 33244242
PMC: 7685373.
DOI: 10.2147/OTT.S261068.